Načítá se...
Clozapine prescribing in COVID-19 positive medical inpatients: a case series
There is both uncertainty regarding the safety of clozapine in COVID-19 patients owing to limited published data and a lack of consensus on continuing clozapine in patients with severe respiratory infections. COVID-19 is known to induce an acute immune response which can affect haematological parame...
Uloženo v:
| Vydáno v: | Ther Adv Psychopharmacol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493264/ https://ncbi.nlm.nih.gov/pubmed/32974002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320959560 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|